Trial · NCT07883291
SmartEnLite for Nursing Home Residents With Dementia
NCT07883291, Not applicable, Not yet recruiting, Penn State University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. SmartEnLite for Nursing Home Residents With Dementia. Trials, record NCT07883291. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07883291
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- SmartEnLite for Nursing Home Residents With Dementia
- NCT number
- NCT07883291
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 300 participants, estimated
- Lead sponsor
- Penn State University
- Conditions
- Alzheimer's Disease and Related Dementias, Alzheimer Disease and Related Dementias
- Interventions
- Smart Environmental Light (SmartEnLite)
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Agitation level | Week 1:Baseline Week 3:During intervention/control Week 5:Immediately post intervention/control Week 7:2 weeks post intervention/control Week 9:During control/intervention Week 11:During control/intervention Week 13:Immediately post control/intervention | Agitation level will be measured using Cohen-Mansfield Agitation Inventory. |
| Primary | Depression level | Week 1:Baseline Week 3:During intervention/control Week 5:Immediately post intervention/control Week 7:2 weeks post intervention/control Week 9:During control/intervention Week 11:During control/intervention Week 13:Immediately post control/intervention | Depression level will be measured using the Cornell Scale for Depression in Dementia (CSDD) |
| Primary | Apathy level | Week 1:Baseline Week 3:During intervention/control Week 5:Immediately post intervention/control Week 7:2 weeks post intervention/control Week 9:During control/intervention Week 11:During control/intervention Week 13:Immediately post control/intervention | Apathy level will be measured using the Person-Environment Apathy Rating (PEAR) |
| Primary | Frequency and Severity of Behavioral and Psychological Symptoms of Dementia (BPSD) | Week 1:Baseline Week 3:During intervention/control Week 5:Immediately post intervention/control Week 7:2 weeks post intervention/control Week 9:During control/intervention Week 11:During control/intervention Week 13:Immediately post control/intervention | Frequency and Severity of BPSD will be measured using the Neuropsychiatric Inventory (NPI) |
| Primary | Sleep Timing | Week 1:Baseline Week 3:During intervention/control Week 5:Immediately post intervention/control Week 7:2 weeks post intervention/control Week 9:During control/intervention Week 11:During control/intervention Week 13:Immediately post control/intervention | Sleep onset and offset timing data will be collected using the ActLumus, a wearable device. |
| Primary | Mood Status | Week 1:Baseline Week 3:During intervention/control Week 5:Immediately post intervention/control Week 7:2 weeks post intervention/control Week 9:During control/intervention Week 11:During control/intervention Week 13:Immediately post control/intervention | Mood statu will be measured using the Dementia Mood Picture Test. |
| Primary | Sleep Duration | Week 1:Baseline Week 3:During intervention/control Week 5:Immediately post intervention/control Week 7:2 weeks post intervention/control Week 9:During control/intervention Week 11:During control/intervention Week 13:Immediately post control/intervention | Sleep duration will be measured using the ActLumus, a wearable device. |
| Primary | Sleep Quality | Week 1:Baseline Week 3:During intervention/control Week 5:Immediately post intervention/control Week 7:2 weeks post intervention/control Week 9:During control/intervention Week 11:During control/intervention Week 13:Immediately post control/intervention | Sleep quality will be measured using the ActLumus, a wearable device. |
| Primary | Sleep stability of rest-activity rhythms | Week 1:Baseline Week 3:During intervention/control Week 5:Immediately post intervention/control Week 7:2 weeks post intervention/control Week 9:During control/intervention Week 11:During control/intervention Week 13:Immediately post control/intervention | Sleep stability of rest-activity rhythms will be measured using the ActLumus, a wearable device. |
| Primary | Occurrence of Adverse Effects | Week 1:Baseline Week 3:During intervention/control Week 5:Immediately post intervention/control Week 7:2 weeks post intervention/control Week 9:During control/intervention Week 11:During control/intervention Week 13:Immediately post control/intervention | Occurrence of adverse effects related to lights will be evaluated using a checklist, which include deteriorated behavioral and psychological symptoms of dementia (BPSD), skin rash, eye irritation, dizziness, nausea, other reactions. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R01AG100732 | SmartEnLite: A Smart Environmental Lighting Intervention to Improve Behaviors and Sleep for Nursing Home Residents Living with Dementia | Jao, Ying-Ling; Wang, Julian | PENNSYLVANIA STATE UNIVERSITY, THE | NATIONAL INSTITUTE ON AGING | 2026 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07883291
GET https://conductscience.org/api/trials/v1/NCT07883291/registered